free access to hypertension and diabetes medicines among the elderly: a reality yet to be constructed acesso gratuito a medicamentos para hipertensão e diabetes em idosos: uma realidade a ser construída

Clicks: 180
ID: 256559
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #368 of 587 articles by views in iberian conference on information systems and technologies, cisti

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 587 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The study evaluated free access to hypertension and diabetes medicines and the reasons reported for lack of access. The sample included 4,003 elderly people living in Primary Care Unit coverage areas from 41 Southern and Northeastern Brazilian cities. Free access was higher in the Northeast (62.4%). The strategy of the Family Health Program (Programa Saúde da Família - PSF) was more effective in providing access than the traditional model, with higher results in the Northeast (61.2%) than in the South (39.6%). Around 20% of medicines included in the Hypertension and Diabetes Program and 26% of those included in the National Essential Medicines List (RENAME) were paid out of pocket. In the Northeast, 25% of insulin and 32% of oral antidiabetics were paid out of pocket. Unavailability in the public sector and a lack of money determined the lack of access. Although the PSF, Hypertension and Diabetes Program and RENAME expanded free access, supplies were insufficient. A greater connection between programs and a clear definition of responsibilities can improve medicine acquisition process, increasing the effectiveness of pharmaceutical assistance.
O estudo avaliou o acesso gratuito a medicamentos para hipertensão e diabetes e os motivos para a falta de acesso. A amostra incluiu 4.003 idosos residentes na área das unidades básicas de saúde (UBS) de 41 municípios do Sul e do Nordeste brasileiro. O acesso gratuito foi maior no Nordeste (62,4%). O Programa Saúde da Família (PSF) teve mais impacto sobre o acesso que o modelo tradicional, sendo maior no Nordeste (61,2%) que no Sul (39,6%). Cerca de 20% dos medicamentos do Programa Nacional para Hipertensão Arterial e Diabetes Mellitus e 26% da Relação Nacional de Medicamentos Essenciais (RENAME) foram pagos. No Nordeste, 25% da insulina e 32% dos antidiabéticos orais foram pagos. Indisponibilidade no setor público e falta de dinheiro foram determinantes da falta de acesso. Embora o PSF, o Programa Nacional para Hipertensão e Diabetes e a RENAME ampliem o acesso gratuito, o suprimento foi insuficiente. Maior integração entre programas e clara definição de responsabilidades podem otimizar a aquisição de medicamentos, aumentando a efetividade da assistência farmacêutica.
Reference Key
paniz2010cadernosfree Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vera Maria Vieira Paniz, Anaclaudia Gastal Fassa, Luiz Augusto Facchini, Roberto Xavier Piccini, Elaine Tomasi, Elaine Thumé, Denise Silva da Silveira, Maria Aparecida Rodrigues, Marlos Rodrigues Domingues, Andréa Dâmaso Bertoldi
Are you one of these authors? Claim your profile
Journal iberian conference on information systems and technologies, cisti
Year 2010
DOI
10.1590/S0102-311X2010000600010
URL
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2010000600010
Keywords
hypertension diabetes mellitus hipertensão diabetes mellitusmedicinepublic aspects of medicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.